Neuralstem Gains on Stem Cell Therapy for Paralyzed Rats

Neuralstem Inc., a biotechnology company with no approved products, gained the most ever after saying its stem cell treatment restored paralyzed rats’ ability to move in an early study.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.